Related by context. All words. (Click for frequent words.) 72 AVONEX ® 69 Evoltra ® 69 vidofludimus 69 novel VDA molecule 68 ® bortezomib 68 evaluating tivozanib 68 forodesine 68 CIMZIA TM certolizumab pegol 68 Xeloda ® 68 Cimzia TM 68 INTEGRILIN R eptifibatide Injection 67 LymphoStat B belimumab 67 retinal vein occlusion induced 67 A1PI 67 corticosteroid dexamethasone 67 mitoxantrone plus 67 humanized therapeutic 67 relapsing multiple sclerosis 66 Cimzia ® certolizumab pegol 66 INSPIRE Trial Phase III 66 ACTEMRA TM 66 BENLYSTA ® 66 catheter occlusion 66 GVAX ® 66 INCB# [001] 66 budesonide foam 66 Avonex interferon beta 1a 66 thetreatment 66 metaglidasen 66 Ixempra 66 dimebon latrepirdine 66 omacetaxine mepesuccinate 66 CYT# potent vascular disrupting 66 CIMZIA ™ 66 LymphoStat B TM 66 antibody MAb 66 Amgen Neulasta R 66 orally inhaled migraine 66 Zorbtive TM 66 acyclovir Lauriad R 66 Phase IIb clinical trials 66 R sorafenib tablets 66 pain palliation 66 relapsed MM 66 ® lenalidomide 66 volociximab 66 CTAP# Capsules 66 SPRYCEL ® 66 alvespimycin 65 phase IIb study 65 hormone LHRH antagonist 65 liposomal formulation 65 COLAZAL R 65 YONDELIS 65 ALN VSP Phase 65 Phase IIa trials 65 IMiDs 65 interferon gamma 1b 65 HQK 65 Amrubicin 65 Hsp# Inhibitor 65 Soliris eculizumab 65 Amgen Neulasta ® 65 Phase IIIb clinical 65 dirucotide MBP# 65 Zemplar Capsules 65 3 registrational trial 65 formerly LymphoStat B 65 azilsartan medoxomil 65 SYN# 65 deforolimus 65 THALOMID 65 Catena ® 65 virus HCV protease inhibitor 65 novel histone deacetylase 65 oncolytic virus therapies 65 TEMSO 65 humanized interleukin 6 65 metastatic malignant 65 teriflunomide 65 CIMZIA TM 65 DexaSite 65 RAPTIVA 65 alemtuzumab Campath 64 RANK Ligand inhibitor 64 successfully commercialize Iluvien 64 Besivance 64 schizophrenia CIAS 64 Clolar ® 64 desvenlafaxine succinate 64 Trobalt 64 OvaRex R 64 Aloxi injection 64 brivaracetam 64 omega interferon 64 evaluating satraplatin 64 rasagiline tablets 64 oral prodrug 64 MKC# MT 64 Canvaxin TM 64 HuMax 64 Peginterferon alfa 2b 64 refractory cutaneous T 64 Achieves Primary Endpoint 64 Archexin 64 refractory chronic lymphocytic 64 Degarelix 64 Dacogen injection 64 TELINTRA 64 Troxatyl 64 Phase 1a clinical 64 Phase #b/#a trial 64 AAG geldanamycin analog 64 ORENCIA ® 64 lumiliximab 64 induced macular edema 64 opioid induced bowel dysfunction 64 Natalizumab 64 INTEGRILIN ® 64 optimal dosing regimens 64 Tramiprosate ALZHEMED TM 64 Tarceva TM 64 aldehyde dehydrogenase ALDH2 deficiency 64 Personalized Immunotherapy 64 Alzhemed TM 64 generation purine nucleoside 64 mertansine 64 Frova ® 64 LEVADEX ™ 64 MOVIPREP R 64 Zavesca r 64 Meets Primary Endpoint 64 Aryplase 64 PrevOnco ™ 64 PLX STROKE targeting 64 Somatuline Depot 64 CCR9 antagonist 64 treatment naïve genotype 64 sargramostim 64 Ketotransdel 64 Rebif interferon beta 1a 64 nalbuphine ER 64 adalimumab Humira 64 novel therapeutic antibodies 64 methylnaltrexone bromide 64 CRMD# 64 acetonide FA 64 ORENCIA R 64 regorafenib 64 ZEVALIN ® 64 Hormone Refractory Prostate Cancer 64 Ophena TM 64 RhuDex R 64 Neulasta R 64 hypoxia activated prodrug 64 Targretin capsules 64 motesanib 64 oral methylnaltrexone 64 IMA# 64 octreotide implant 64 beta 1a 64 Androxal TM 64 sulfonylurea glimepiride 64 Phase #b/#a clinical 64 5 lipoxygenase inhibitor 64 hereditary emphysema 63 Zenvia ™ 63 SNT MC# 63 oral ridaforolimus 63 aplindore 63 calcineurin inhibitor 63 oral salmon calcitonin 63 BrachySil TM 63 maximally tolerated lipid lowering 63 HCD# [002] 63 TBC# 63 M# rationally 63 Spiegelmer ® 63 LUCENTIS 63 UVIDEM 63 Crofelemer budesonide foam 63 interferon beta therapy 63 paclitaxel Taxol ® 63 KNS # 63 orally administered inhibitor 63 dasatinib Sprycel 63 Allovectin 7 63 PI3K/Akt pathway inhibitor 63 AGILECT R 63 Ocrelizumab 63 metastatic colorectal carcinoma 63 RhuDex ® 63 MoxDuo IR 63 novel orally inhaled 63 Tykerb lapatinib 63 Vidaza R 63 lintuzumab SGN 63 TAXUS TM 63 PHX# 63 agonistic human 63 Betaferon R 63 progressive metastatic prostate 63 Panzem R 63 Firazyr 63 MKC# 63 sitaxsentan 63 FOLOTYN ® 63 vaccines oncolytic virus 63 REMINYL ® 63 Benlysta belimumab 63 Capesaris 63 Daclizumab 63 PREOS R 63 ZACTIMA 63 registrational trial 63 Pruvel 63 Fludara ® 63 oral picoplatin 63 FOLFOX6 chemotherapy regimen 63 Somatuline R Depot 63 vinorelbine tartrate 63 torsemide ER 63 albiglutide 63 OncoVex 63 Testim R 63 kidney urologic 63 miconazole Lauriad ® 63 Targeted Chemotherapy 63 rheumatoid arthritis psoriatic arthritis 63 refractory metastatic colorectal cancer 63 histamine dihydrochloride 63 Adjuvant Treatment 63 clevidipine 63 GetGoal Phase III 63 novel oral anticoagulant 63 Campath ® 63 sunitinib malate 63 hoFH 63 baminercept 63 RoACTEMRA 63 clonidine hydrochloride 63 phase IIb clinical 63 assessing T DM1 63 R pegaptanib sodium 63 Actimmune ® 63 Quinamed 63 Phase 1b clinical trials 63 inhaled liposomal ciprofloxacin 63 GOUT 63 Aflibercept 63 BCR ABL inhibitor 63 Elagolix 63 Raptiva ® 63 PSMA ADC 63 xanthine oxidase inhibitor 63 Q#IR 63 Cleviprex TM clevidipine 63 TELINTRA R 63 cyclophosphamide chemotherapy 63 Pemetrexed 63 SUPPRELIN R LA 63 GAMMAGARD 63 selective modulator 63 ANTEGREN 63 plus gemcitabine 63 Uvidem 63 EDEMA3 63 Nexavar ® 63 ZOLINZA 63 AFREZZA TM 63 CCX# B 63 Glypromate 63 midstage clinical 62 custirsen 62 neratinib 62 cannabinor 62 Phase 2b Clinical Trial 62 phase IIa clinical 62 R Saizen R 62 SinuNase ™ 62 vapreotide acetate 62 icatibant 62 orally inhaled 62 cutaneous T 62 Panzem R NCD 62 Glufosfamide 62 OMNARIS Nasal Spray 62 Combination REOLYSIN R 62 oral FTY# 62 goserelin 62 Plicera 62 Empatic ™ 62 Myocet 62 IL# PE#QQR 62 Safinamide 62 sorafenib tablets 62 Gleevec Glivec 62 Fx #A 62 novel emulsion formulation 62 GVAX R 62 sapacitabine CYC# 62 CytoFabTM 62 MYDICAR ® 62 farletuzumab 62 galiximab 62 OvaRex ® MAb 62 Oral NKTR 62 elotuzumab 62 gemcitabine Gemzar ® 62 systemic anaplastic large 62 PD LID 62 EGS# 62 TM Drug Eluting 62 aromatase inhibitor AI 62 dextromethorphan quinidine 62 occlusion PAO 62 investigational immunotherapy 62 Vfend 62 paclitaxel poliglumex 62 Dual Opioid 62 DEB# 62 Phase 1b trial 62 hyperphenylalaninemia HPA due 62 including eniluracil ADH 62 Amigal TM 62 novel synthetic PEGylated 62 Bayer HealthCare Onyx Pharmaceuticals 62 OMNARIS HFA 62 evaluating REVLIMID 62 trospium 62 Laquinimod 62 targeted antifolate 62 Panzem ® 62 novel nucleoside analog 62 HuLuc# 62 bone marrow reticulin deposition 62 trial evaluating PRX# 62 demonstrated antitumor activity 62 Serdolect ® 62 Neulasta ® 62 relapsed refractory multiple myeloma 62 evaluating Actimmune 62 HuMax TAC 62 investigational antiplatelet agent 62 brain metastases originating 62 ALN HPN 62 Temsirolimus 62 PROVENGE ® 62 advanced hepatocellular carcinoma 62 oral beclomethasone dipropionate 62 Vandetanib 62 OncoGel 62 Vectibix panitumumab 62 Behcet uveitis 62 XL# anticancer compounds 62 arthritis PsA 62 biologic antibody 62 XP# XP# 62 Telik logo TELINTRA 62 incyclinide 62 evaluating picoplatin 62 pediatric acute lymphoblastic 62 PEGylated Fab fragment 62 ruxolitinib 62 Phenoptin 62 Traficet EN 62 tramiprosate Alzhemed TM 62 inhaled treprostinil 62 Nipent R 62 seliciclib CYC# 62 nucleotide analog 62 DIFICID ™ 62 plus prednisone prednisolone 62 Sebivo 62 BRIM2 62 reduce serum phosphate 62 MabThera Rituxan 62 personalized cellular immunotherapy 62 PresbyLens ® 62 OZURDEX 62 Initiates Enrollment 62 Abbokinase 62 oral deforolimus 62 diabetic neuropathic pain 62 Pertuzumab 62 Romidepsin 62 Temodar ® 62 Virulizin ® 62 Boniva ibandronate 62 prokinetic agent 62 Arcalyst 62 FOLFOX6 62 de novo kidney transplant 62 relapsing remitting MS RRMS 62 docetaxel Taxotere ® 62 verteporfin 62 REMUNE R 62 sodium thiosulfate STS 62 CDP# 62 Saforis 62 Increlex ® 62 CRLX# 62 Onyx Pharmaceuticals Announces 62 PLX MS 62 Trofex TM 62 Initiated Phase 62 candidate XP# 62 adjuvant GIST 62 IMiDs ® compound 62 estramustine 62 visilizumab 62 pediatric Crohn disease 62 MAGE A3 ASCI 62 pertuzumab 62 dose escalation clinical 62 Aplidin 62 phase III isavuconazole 62 Phase Ib clinical 62 TYSABRI natalizumab 62 Aloxi R 62 Announces Poster Presentations 62 AzaSite TM 62 TAXUS Element Paclitaxel Eluting 62 THALOMID R 62 Azmacort R 62 Phase III ADT 62 Initiate Phase 62 PRT# 62 relapsing forms 62 fludarabine phosphate 62 Insegia 62 serum uric acid sUA 62 multicenter Phase II 62 Bicifadine 62 R bortezomib 62 Pimavanserin 62 Mipomersen 61 Glatiramer Acetate 61 approved incretin mimetic 61 refractory metastatic 61 efaproxiral 61 R bendamustine hydrochloride 61 entinostat 61 gastrin analogue TT 61 ATRA IV 61 AN# topical anti 61 STELARA TM 61 pitavastatin 61 non metastatic osteosarcoma 61 PEG PAL 61 Hodgkin lymphoma HL 61 Dyloject TM 61 cancer neuroendocrine tumor 61 drug eluting coronary stent 61 brand ciclesonide HFA 61 Clonicel 61 AzaSite Plus 61 oropharyngeal candidiasis OPC 61 tolevamer 61 Annamycin 61 SomatoKine 61 DUROS 61 IIa trial 61 phase IIb trial 61 patients receiving myelosuppressive 61 Phase Ib study 61 QVAR 61 telomerase therapeutic 61 Neupro R 61 relapsed CLL 61 valtorcitabine 61 ospemifene 61 humanised monoclonal antibody 61 drug Treanda 61 oxymorphone ER 61 Intravitreal 61 ONTAK 61 FUSILEV enhances 61 relapsed multiple myeloma 61 small molecule tyrosine 61 selective S#P# receptor agonist 61 aplastic anemia AA 61 R#/MEM # 61 ularitide 61 Patients Treated With 61 nilotinib Tasigna 61 ancrod 61 Golimumab 61 Marqibo TM 61 Thalomid ® 61 polymer platinate 61 Neupogen ® 61 Anavex #-# 61 headache nasopharyngitis 61 Revlimid lenalidomide 61 tremelimumab 61 oxaliplatin Eloxatin 61 Angiox ® 61 Pyridorin 61 mGluR2 positive 61 Prodarsan R 61 cystinosis patients 61 TASKi3 61 Locteron ® 61 ELACYT 61 Ozarelix 61 PEGylated interferon beta 1a 61 CHOP chemotherapy 61 Granted Orphan Drug 61 Adenoscan R 61 Phase Ib IIa 61 PDE4 inhibitor 61 non nucleoside inhibitor 61 candidate deforolimus 61 Omacetaxine 61 Exelixis compounds 61 Detrol Detrol LA 61 Telatinib 61 mg/m2 cohort 61 rhIGF-I/rhIGFBP-3 61 Syndrome RLS 61 REGN# 61 INS# [001] 61 immunomodulatory therapy 61 Completes Patient Enrollment 61 Diabetic Macular Edema DME 61 targeted radiotherapeutic 61 ONCASPAR 61 Plenaxis TM 61 R#/MEM 61 neovascular diseases 61 CINTREDEKIN BESUDOTOX 61 Lixivaptan 61 class mGluR5 inhibitor 61 oral taxane 61 certolizumab 61 TRISENOX 61 ProSavin 61 product Fentanyl TAIFUN 61 Xcytrin R 61 8mg/kg 61 PEGylated anti 61 EOquin TM 61 oral ghrelin agonist 61 bardoxolone methyl 61 Xanafide 61 HCl Tablets 61 recurrent glioblastoma 61 REBETOL combination 61 Tovaxin TM 61 VBLOC vagal blocking 61 Valdoxan 61 compound INCB# 61 multicenter Phase 61 TRO# 61 ADP receptor antagonist 61 intravesical infusion therapy 61 Demonstrates Sustained 61 ulimorelin 61 EVIZON ™ 61 Xyfid TM 61 dual reuptake inhibitor 61 ACOMPLIA R 61 AMEVIVE 61 CIMZIA r 61 EOquin TM phase 61 cetuximab Erbitux R 61 cisplatin gemcitabine 61 monoclonal antibody IgG1 Mab 61 OZURDEX ® 61 Zavesca ® 61 Proquin XR 61 Tezampanel 61 ZEGERID Capsules 61 Macular edema 61 oral anti arrhythmic 61 Genz # 61 MEK inhibitor 61 XAGRID 61 Pseudomonas aeruginosa P. aeruginosa 61 somatostatin analog 61 TO AVOID PREGNANCY WHILE 61 RAPTIVA r 61 Evoltra 61 HuMax EGFr 61 refractory gout 61 PEG SN# 61 Cetuximab Erbitux 61 BEMA TM Fentanyl 61 investigational antiplatelet 61 TEMODAL 61 LymphoStat B 61 GW# [003] 61 aflibercept VEGF Trap 61 Theratope 61 Cipralex ® 61 Vitrasert R 61 Selective Electrochemical Tumor Ablation 61 6R BH4 61 TRIOLEX HE# APOPTONE HE# 61 COMT inhibitors 61 initiate Phase IIa 61 ReN# stem cell 61 cilengitide 61 receptor tyrosine kinase inhibitor 61 Tasimelteon 61 taxane refractory 61 Hervé Hoppenot President 61 docetaxel Taxotere R 61 chronic thromboembolic pulmonary 61 adult chronic ITP 61 Velcade bortezomib 61 VELCADE melphalan 61 elacytarabine 61 HuMax CD4 61 glatiramer 61 Carbidopa 61 INTEGRILIN 61 metastatic hormone refractory 61 Zenvia TM 61 Savella ® 61 adecatumumab MT# 61 rALLy clinical trial 61 LibiGel ® 61 non splenectomized 61 Solazed TM 61 Cx# [002] 61 eluting stent 61 decitabine 61 5 fluorouracil leucovorin 61 SinuNase TM 61 candidates Azedra TM 61 AVAPRO 61 Phase 2a clinical 61 accumulate preferentially 61 levocetirizine 61 oxypurinol 61 Surfaxin LS 61 inhaled iloprost 61 TKM ApoB 61 steroid refractory ulcerative 61 DepoDur 61 maximally tolerated 61 protein tyrosine phosphatase 1B 61 Ozurdex 61 molecular imaging radiopharmaceutical 61 E1 INT TM 61 Onrigin 61 Alzheimer disease cognitive impairment 61 pan histone deacetylase 61 fusion enhancers 61 Xcellerated T Cells 61 Bezielle 61 NSABP C 61 recurrent metastatic 61 CINQUIL 61 dirucotide 61 Alvesco R 61 candidate TNFerade biologic 61 recurrent glioblastoma multiforme 61 evaluating mipomersen 61 CLARITY study 61 Oracea TM 61 pegylated liposomal doxorubicin 61 Initiate Clinical Trial 61 inflammatory PDE 61 overactive bladder syndrome 61 plasma kallikrein inhibitor 61 Camptosar ® 61 Increlex R 61 Sanofi Aventis Taxotere 61 MACUGEN 61 axitinib 61 Lodotra 61 Glybera 61 PF # [002] 61 tanespimycin 61 OHR/AVR# 61 reslizumab 61 indolent follicular non 61 Nicole Onetto MD 61 MKC# MKC# PP 61 Hepatitis C HCV 61 Immunotherapeutic 61 IMiDs ® 61 HyperAcute 61 ELIQUIS 61 Pivotal Phase III 61 IAP inhibitor 61 maximally tolerated dose 60 Empatic TM 60 naïve HCV 60 delivers fluocinolone acetonide FA 60 erlotinib Tarceva ® 60 SNT-MC#/idebenone 60 Raptiva R 60 Allovectin 7 ® 60 adjuvant cisplatin 60 R vitespen 60 use transdermal sumatriptan 60 radiation sensitizer 60 Initiates Phase II 60 Octreolin 60 velafermin 60 doxercalciferol 60 ChronVac C R 60 ABILIFY ® 60 Demonstrates Significant 60 Arranon 60 tezampanel NGX# 60 thalidomide Thalomid 60 pralatrexate injection folate analogue 60 R sevelamer hydrochloride 60 adenosine injection 60 intranasal formulation 60 darapladib 60 investigational humanized monoclonal antibody 60 JAK#/JAK# inhibitor CYT# 60 TYZEKA 60 KRAS mutations occur 60 opioid naive 60 Pivotal Phase 60 Budesonide foam crofelemer 60 Evamist TM 60 denileukin diftitox 60 romidepsin 60 ZANAFLEX CAPSULES ® tizanidine 60 HCV protease inhibitors 60 gemtuzumab ozogamicin 60 RhuDex ™ 60 tizanidine hydrochloride short 60 XL# XL# 60 SUCCEED trial 60 Fc fusion protein 60 oral talactoferrin 60 YONDELIS R 60 FDA APPROVES 60 APEX PD 60 small molecule Hedgehog 60 Rebif ® 60 MEND CABG II 60 Relovair 60 rilonacept 60 treatment naive genotype 60 Urocidin 60 BRAF mutant 60 Fenoglide 60 ALVESCO ® 60 IMiDs R 60 Zalypsis 60 OMNARIS 60 TNF Tumor Necrosis Factor 60 ABILIFY R 60 MBP# dirucotide 60 VIVITROL ® 60 undergoing elective percutaneous 60 Ceflatonin R 60 NV1FGF 60 salmeterol fluticasone 60 Levoleucovorin 60 Perforomist ™ Inhalation Solution 60 Certolizumab pegol 60 Beyond Advair 60 JAK2 Inhibitor 60 Boceprevir 60 lenalidomide dexamethasone 60 fosbretabulin 60 cediranib 60 Genentech Rituxan 60 Initiates Phase III 60 Asentar 60 NeuroSTAT ® 60 QVA# 60 PROMACTA ® 60 Denufosol 60 histone deacetylase HDAC inhibitor 60 developing Bicifadine serotonin 60 phase Ib 60 PNP inhibitor 60 Tavocept 60 CR# vcMMAE 60 TTF Therapy 60 inflammatory autoimmune diseases 60 PORxin TM 60 plus prednisone 60 herpetic keratitis 60 Keppra XR 60 Pruvel TM 60 platelet aggregation inhibitor 60 weekly subcutaneous injections 60 GRNVAC1 60 Hedgehog antagonist 60 develop HBV reactivation 60 IIb clinical trial 60 NGX# 60 BCG refractory 60 Alequel ™ 60 ICA # 60 Trofex 60 lexidronam injection 60 CCX# 60 FOR FURTHER INFORMATION ABOUT 60 Frova R 60 quetiapine fumarate 60 Corlux 60 AVASTIN 60 Vertex hepatitis C 60 bleeding pallor 60 UPLYSO 60 ARIKACE ™ 60 RELOVAIR ™ 60 Viprinex TM 60 Vidaza azacitidine 60 mcg BID 60 ALVESCO R 60 TRISENOX R arsenic trioxide 60 Certolizumab 60 Maribavir 60 DAC HYP 60 Gattex 60 metastatic pancreatic 60 LAB CGRP 60 ThermoDox R 60 myocardial infarction ventricular fibrillation 60 P#X# antagonist 60 huN# DM1 60 recurrent NSCLC 60 melphalan prednisone 60 Simulect 60 EXPAREL TM 60 registrational Phase 60 nasal calcitonin product 60 subcutaneous formulation 60 IRX 2 60 dose cohort 60 endothelin antagonist 60 Pirfenidone 60 Mirapexin 60 Dacogen decitabine 60 Phase III multicenter 60 Tesetaxel 60 Perforomist TM formoterol fumarate 60 Phase #/#a trial 60 Generx TM 60 JAK inhibitor 60 Xenazine ® 60 glucokinase activator 60 Adentri 60 Factor VIIa 60 SUTENT ® 60 Bendamustine 60 isoform selective 60 DCVax ® Brain 60 drug figitumumab 60 KSP inhibitor 60 TH# [003] 60 PXD# 60 Qutenza TM 60 etanercept Enbrel 60 Aptocine 60 Istalol 60 pioglitazone hydrochloride 60 TRANSDUR ® 60 HepeX B 60 Mg Usa 60 Cethrin 60 recurrent metastatic ovarian cancer 60 R abatacept 60 Inhalation Solution 60 lenalidomide Revlimid R 60 aliskiren amlodipine 60 Nexavar sorafenib 60 Vidaza ® 60 Silodosin 60 AERx ® 60 pegylated interferons 60 CAMPATH 60 dacetuzumab 60 BCR ABL inhibitors 60 STRIANT ® testosterone buccal 60 Dasatinib 60 concurrent chemoradiation 60 cosmetic cosmeceutical products 60 EndoTAGTM 1 60 Cetrorelix 60 Kepivance 60 metastatic colorectal 60 UCB Keppra 60 Bosutinib 60 gemcitabine carboplatin 60 riociguat 60 Humira adalimumab 60 BENLYSTA TM 60 immune modulating 60 initiate Phase 2b 60 PDE# inhibitors 60 coronary stent merged 60 Neuromodulation System 60 BARACLUDE R 60 intermittent dosing 60 systemically administered 60 ARCALYST ® 60 VYVANSE TM lisdexamfetamine 60 Forodesine HCl 60 mTOR mammalian target 60 Sirolimus eluting Coronary Stent 60 diarrhea predominant irritable 60 Microplasmin 60 IV APAP 60 CHAMPION PCI 60 OSMOPREP 60 Tibotec Therapeutics division 60 Raptiva efalizumab 60 Acute myelogenous leukemia 60 Presents Preclinical 60 mGluR5 negative 60 BEMA Granisetron 60 LUNESTA TM 60 lucinactant 60 hormone agonist 60 aerosolized AAT 60 PEGINTRON TM 60 interferon alfacon 1 60 DU #b 60 DURIN TM 60 vascular disrupting agent 60 ARCALYST 60 DPP4 inhibitor 60 immunotherapeutic vaccine 60 HGS# 60 Zelrix 60 CYCLOSET 60 FUSILEV ® 60 LEUKINE 60 Solazed 60 Sodium oxybate 60 Roche Xeloda 60 Ketotransdel TM 60 Triapine 60 Investigational Oral 60 EnteroMedics proprietary neuroblocking technology 60 Naglazyme 60 MGN# 60 HepeX B TM 60 CONBRIZA 60 DIFICID 60 Elotuzumab 60 mGluR2 NAM 60 LHRH antagonist 60 RITUXAN ® 60 Icatibant 60 CTA# Injection 60 osteolytic bone disease 60 Treanda 60 QuadraSphere 60 Symadex 60 ALN PCS 60 multicenter multinational 60 Folfox 60 PRESEPT study 60 Actimmune R 60 HuMax CD#b 60 ACAPODENE TM 60 cMET 60 IMPDH inhibitor 60 Argatroban 60 dual endothelin receptor antagonist 60 cyclophosphamide doxorubicin vincristine 60 Cloretazine R VNP#M 60 delivery polymer matrix 60 alvimopan 60 Bepreve TM 60 Lymphoseek ® 60 tumor vascular disrupting 60 Cimzia certolizumab pegol 60 unresectable stage 60 COSIRA trial 60 investigational monoclonal antibody 60 REGEN trial 60 oral Hycamtin 60 Onco TCS 60 relapsed leukemia 60 ankylosing spondylitis psoriatic arthritis 60 SUPPRELIN LA 60 Sanctura XR 60 budiodarone 60 midstage trials 60 HoFH 60 Syncria 60 E2F Decoy 60 PARGLUVA 60 bendamustine 60 HP Acthar Gel repository 60 deCODE AF TM 60 Cloretazine ® 60 Onalta ™ 60 torezolid phosphate 60 Phase 2a trial 60 peptidic compound